THE CANCER ADVOCACY COALITION OF CANADA (CACC), IN ITS ANNUAL REPORT CARD ON CANCER IN CANADA(TM) CALLS FOR GREATER INNOVATION IN CANCER CARE TO IMPROVE PATIENT OUTCOMES
Cancer Advocacy Coalition of Canada Provides New Insights into Current Cancer Landscape
Toronto, ON, April 11, 2012 – The Cancer Advocacy Coalition of Canada (CACC) reveals in its 2011-2012 Report Card on Cancer in Canada™ that innovative solutions are needed to improve the current landscape for cancer care, prevention and treatment in Canada. The Report Card highlights new innovations that should be adopted more widely and quickly, such as molecular testing for targeted therapies in lung cancer.
“This year’s Report Card demonstrates there is a great need for innovation in our battle against cancer, but it also highlights the strides that are already being made in discovering and developing better, more efficient approaches to treatment,” says Dr. James Gowing, Past Chair of the CACC and current Co-Chair of the Report Card on Cancer in Canada Editorial Committee. “New biomarker identification is helping us to personalize treatment for lung cancer, saving money and lives. Work towards eliminating stigma associated with lung cancer will ensure fair access to treatment and prevention. Innovative approaches to fighting cancer are becoming more common place, leading us to the cusp of an important era in cancer care.”
To read the article about lymphoma, by Lymphoma Canada’s Executive Director, go to Page 39.